These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. Developing a cognitive dysfunction risk score for use with opioid-dependent persons in drug treatment. Copenhaver MM; Sanborn V; Shrestha R; Mistler CB; Sullivan MC; Gunstad J Drug Alcohol Depend; 2021 Jul; 224():108726. PubMed ID: 33930640 [TBL] [Abstract][Full Text] [Related]
30. Genetic risk score based on the prevalence of vertebral fracture in Japanese women with osteoporosis. Zhou H; Mori S; Ishizaki T; Takahashi A; Matsuda K; Koretsune Y; Minami S; Higashiyama M; Imai S; Yoshimori K; Doita M; Yamada A; Nagayama S; Kaneko K; Asai S; Shiono M; Kubo M; Ito H Bone Rep; 2016 Dec; 5():168-172. PubMed ID: 28580384 [TBL] [Abstract][Full Text] [Related]
31. Genetic risk score based on the lifetime prevalence of femoral fracture in 924 consecutive autopsies of Japanese males. Zhou H; Mori S; Ishizaki T; Tanaka M; Tanisawa K; Mieno MN; Sawabe M; Arai T; Muramatsu M; Yamada Y; Ito H J Bone Miner Metab; 2016 Nov; 34(6):685-691. PubMed ID: 26462479 [TBL] [Abstract][Full Text] [Related]
32. Predicting mortality with biomarkers: a population-based prospective cohort study for elderly Costa Ricans. Rosero-Bixby L; Dow WH Popul Health Metr; 2012 Jun; 10(1):11. PubMed ID: 22694922 [TBL] [Abstract][Full Text] [Related]
33. Layperson-Oriented versus Clinical-Based Models for Assessing 10-Year Incidence of Coronary Heart Disease: National FINRISK Study. Qiao Q; Laatikainen T; Gao W; Pitkäniemi J; Vartiainen E Int J Vasc Med; 2011; 2011():823782. PubMed ID: 22028973 [TBL] [Abstract][Full Text] [Related]
34. Homogeneity in the relationship of serum cholesterol to coronary deaths across different cultures: 40-year follow-up of the Seven Countries Study. Menotti A; Lanti M; Kromhout D; Blackburn H; Jacobs D; Nissinen A; Dontas A; Kafatos A; Nedeljkovic S; Adachi H Eur J Cardiovasc Prev Rehabil; 2008 Dec; 15(6):719-25. PubMed ID: 19050437 [TBL] [Abstract][Full Text] [Related]
35. Prediction of the risk of cardiovascular mortality using a score that includes glucose as a risk factor. The DECODE Study. Balkau B; Hu G; Qiao Q; Tuomilehto J; Borch-Johnsen K; Pyörälä K; ; Diabetologia; 2004 Dec; 47(12):2118-28. PubMed ID: 15662552 [TBL] [Abstract][Full Text] [Related]
36. Framingham-based tools to calculate the global risk of coronary heart disease: a systematic review of tools for clinicians. Sheridan S; Pignone M; Mulrow C J Gen Intern Med; 2003 Dec; 18(12):1039-52. PubMed ID: 14687264 [TBL] [Abstract][Full Text] [Related]
37. Prediction of mortality from coronary heart disease among diverse populations: is there a common predictive function? Diverse Populations Collaborative Group Heart; 2002 Sep; 88(3):222-8. PubMed ID: 12181209 [TBL] [Abstract][Full Text] [Related]
38. ApoE polymorphism in a small Mediterranean island: relationships with plasma lipids, lipoproteins and LDL particle size. Barbagallo CM; Polizzi F; Severino M; Rizzo M; Vivona N; Onorato F; Caldarella R; Cefalù AB; Noto D; Notarbartolo A; Averna MR Eur J Epidemiol; 2001; 17(8):707-13. PubMed ID: 12086087 [TBL] [Abstract][Full Text] [Related]
39. The current status of primary prevention in coronary heart disease. Pater C Curr Control Trials Cardiovasc Med; 2001; 2(1):24-37. PubMed ID: 11806770 [TBL] [Abstract][Full Text] [Related]